RSS

extension

In celebration of its 35th year, speciality enzyme company, Biocatalysts, has made a major investment into its future manufacturing capacity. more

News

A long-term contract extension has been agreed by Proteon Therapeutics and Lonza Pharma & Biotech for the commercial supply of the investigational vonapanitase’s active pharmaceutical ingredient (API). more

News

Catalent Pharma Solutions has announced the multi-site expansion of its analytical and process development capabilities for biologics more

News